Cargando…
From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
Autores principales: | Yeh, Ming-Lun, Yu, Ming-Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577339/ https://www.ncbi.nlm.nih.gov/pubmed/37718552 http://dx.doi.org/10.3350/cmh.2023.0359 |
Ejemplares similares
-
Embracing the principles of practice transfer to get the word out on the new metabolic dysfunction-associated steatotic liver disease nomenclature
por: Carr, Rotonya M.
Publicado: (2023) -
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
por: Yoon, Eileen Laurel, et al.
Publicado: (2023) -
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
por: Eskridge, Wayne, et al.
Publicado: (2023) -
From Nonalcoholic Steatohepatits to Steatotic Liver Disease: A Long Way
por: Cotrim, Helma Pinchemel
Publicado: (2023) -
Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)